Cautions and Caveats to the Treatment of Acquired Hemophilia A
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Successful eradication of acquired factor-VIII-inhibitor using single low-dose rituximab.
Wermke M, von Bonin M, Gehrisch S, Siegert G, Ehninger G, Platzbecker U Haematologica. 2009; 95(3):521-2.
PMID: 19903680 PMC: 2833088. DOI: 10.3324/haematol.2009.017749.
References
1.
Guillet B, Pinganaud C, Proulle V, Dreyfus M, Lambert T
. Myocardial infarction occurring in a case of acquired haemophilia during the treatment course with recombinant activated factor VII. Thromb Haemost. 2002; 88(4):698-9.
View
2.
Kavakli K, Makris M, Zulfikar B, Erhardtsen E, Abrams Z, Kenet G
. Home treatment of haemarthroses using a single dose regimen of recombinant activated factor VII in patients with haemophilia and inhibitors. A multi-centre, randomised, double-blind, cross-over trial. Thromb Haemost. 2006; 95(4):600-5.
View
3.
Hay C, Brown S, Collins P, Keeling D, Liesner R
. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Br J Haematol. 2006; 133(6):591-605.
DOI: 10.1111/j.1365-2141.2006.06087.x.
View
4.
Huth-Kuhne A, Baudo F, Collins P, Ingerslev J, Kessler C, Levesque H
. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica. 2009; 94(4):566-75.
PMC: 2663620.
DOI: 10.3324/haematol.2008.001743.
View
5.
Sperr W, Lechner K, Pabinger I
. Rituximab for the treatment of acquired antibodies to factor VIII. Haematologica. 2007; 92(1):66-71.
DOI: 10.3324/haematol.10553.
View